Elsa R. Flores, PhD, Chair and Senior Members, Department of Molecular Oncology, Co-Leader, Cancer Biology and Evolution Program, Moffitt Cancer Center
Michael Mitchell, PhD, Massachusetts Institute of Technology
Maria-Luisa Alegre, MD, PhD, Professor, Department of Medicine, Division of Rheumatology, The University of Chicago
Please join the UNC Cancer Network for an online telehealth lecture with Julianne O'Daniel, MS, CGC. She will discuss the role genetics and genomics play in the cancer risk identification process. RN and Allied Health lectures offer ANCC and ASRT continuing education credit (upon approval) for eligible participants. While we invite anyone interested to view our lectures, participants wishing to obtain credit should be connected to a physical site with a coordinator. Please contact us for more information and to be connected with a site coordinator.
Nikolaus Rajewsky, PhD, Scientific Head, Berlin Institute for Medical Systems Biology
Please join the UNC Cancer Network for an online telehealth lecture with Geni Eng, MPH, DrPH; Jennifer Schaal, MD; Beth Smith, RN, MSN, NE-BC. RN/Allied Health lectures offer ANCC and ASRT continuing education credits (upon approval) for eligible participants. While we invite anyone interested to view our lectures, participants wishing to obtain credit should be connected to a physical site with a coordinator. Please contact us for more information and to be connected with your site coordinator.
Join us for the UNC-Duke Viral Oncology and AIDS Malignancy Symposium, featuring Frederick Wang, MD, Brigham and Women's Hospital, Sallie Permar, MD, PhD, Duke Global Health Institute, and Corey Casper, MD, MPH, Fred Hutchinson Cancer Research Center.
The Center for Integrative Chemical Biology and Drug Discovery is hosting a talk by David H. Thompson, PhD, Professor – Organic Chemistry at Purdue University. His presentation is entitled “Development of New Tools for Accelerated Protein Structure Determination and Reaction Discovery."
This conference at the Friday Center is free and open to all kidney cancer patients and survivors.
The advent of new technologies that allow analysis of entire genomes presents many challenges to the researcher. A great deal of information is obtained through genomic sequencing and such information is highly heterogeneous, ranging from frankly uninterpretable to highly informative regarding the risk for future health conditions. Jim Evans, MD, PhD, will discuss some of these challenges and a variety of potential solutions.